Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Pediatr Blood Cancer. 2013 Jan 17;60(7):1161–1164. doi: 10.1002/pbc.24470

Table II.

Toxicity of combination therapy with methotrexate/asparaginase

Adverse event Total events Grade 1 Grade 2 Grade 3
Gastrointestinal
Nausea 1 1
Mucositis 1 1
Pancreatitis Metabolic/laboratory 2 2
AST elevation 9 6 3
ALT elevation 8 6 2
Hyperbilirubinemia Infection 1 1
Febrile neutropenia 2 2
Capillary leak syndrome 1 1
Tumor lysis syndrome 3 3

Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase.

No grade 4 or grade 5 adverse events occurred in the study.